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 Summary 
Chromatin featuring the H3 variant CENP-A at the centromere is critical for its 
mitotic function and epigenetic maintenance. Assembly of centromeric chromatin is 
restricted to G1 phase through inhibitory action of Cdk1/2 kinases in other phases 
of the cell cycle. Here, we identify the two key targets sufficient to maintain cell cycle 
control of CENP-A assembly. We uncovered a single phosphorylation site in the 
licensing factor M18BP1 and a cyclin A binding site in the CENP-A chaperone, HJURP, 
mediating specific inhibitory phosphorylation. Simultaneous expression of mutant 
proteins lacking these residues, results in complete uncoupling from the cell cycle. 
Consequently, CENP-A assembly is fully recapitulated under high Cdk activities, 
indistinguishable from G1 assembly. We find that Cdk-mediated inhibition is 
exerted by sequestering active factors away from the centromere. Finally, we show 
that displacement of M18BP1 from the centromere is critical for the assembly 
mechanism of CENP-A. 
Introduction 
Centromeres are chromosomal loci that drive faithful genome segregation during 
mitotic division (Allshire and Karpen, 2008). The functional foundation of the 
centromere is established by a specialized chromatin structure that features the 
histone H3 variant CENP-A (Black and Cleveland, 2011). This CENP-A-based 
chromatin domain provides a structural platform for formation of the kinetochore 
which links chromosomes to spindle microtubules during mitosis (Cheeseman and 
Desai, 2008; Foltz et al., 2006; Okada et al., 2006). In addition, CENP-A ensures stable 
maintenance of centromere position through an epigenetic, self-propagating 
feedback loop (Black and Cleveland, 2011; Gómez-Rodríguez and Jansen, 2013). 
Support for the epigenetic nature of the centromere comes from naturally occurring 
neocentromeres (Amor et al., 2004; Marshall et al., 2008), where centromere 
proteins vacate the original centromeric DNA sequence and assemble heritably on 
previously naïve chromatin. In addition, ectopic targeting of CENP-A or proteins of 
the centromere complex to a non-centromeric locus was shown to be sufficient to 
initiate a functional and heritable centromere (Barnhart et al., 2011; Hori et al., 
2013; Mendiburo et al., 2011). Consistent with a key role at the core of a positive 
epigenetic feedback loop, CENP-A nucleosomes are long lived and are maintained 
through multiple cell divisions (Bodor et al., 2013; Jansen et al., 2007). The unusually 
slow turnover of CENP-A at each centromere (Falk et al., 2015) indicates that 
replenishment is either equally slow or is limited in time and tied to CENP-A 
redistribution following DNA replication. Indeed, in metazoans, assembly of newly 
synthesized CENP-A is directly linked to cell cycle progression and is initiated 
during mitotic exit and restricted to early G1 phase of the cell cycle (Jansen et al., 
2007; Schuh et al., 2007). 
 Previously we showed that brief inhibition of cyclin dependent kinase 1 and 2 
(Cdk1/2) activities is sufficient to drive CENP-A deposition prior to mitotic exit 
(Silva et al., 2012). This has led to a model where the CENP-A assembly machinery 
is present and poised for activity but is kept inactive throughout S, G2 and M phase, 
until mitotic exit when activities of Cdk1/2 drop, concomitant with the onset of 
CENP-A deposition. Key proteins necessary for the process of CENP-A deposition 
include the Mis18 complex and the CENP-A chaperone HJURP which bears CENP-A-
specific nucleosome assembly activity (Dunleavy et al., 2009; Foltz et al., 2009; Fujita 
et al., 2007). HJURP and M18BP1 (also known as HsKNL2), a member of the Mis18 
complex, are phosphoproteins (Bailey et al., 2016; Dephoure et al., 2008; Kato et al., 
2007; McKinley and Cheeseman, 2014; Müller et al., 2014; Silva et al., 2012; Wang 
et al., 2014) and localize to centromeres in a cell cycle controlled manner, in early 
G1 phase (Dunleavy et al., 2009; Foltz et al., 2009; Fujita et al., 2007; Maddox et al., 
2007), indicating they are putative targets for Cdk regulation. In addition, recent 
work has identified the mitotic kinase Plk1 as a critical component to drive CENP-A 
assembly (McKinley and Cheeseman, 2014). However, while Plk1 is itself a cell cycle 
controlled kinase, it does not restrict CENP-A assembly to G1 phase as it is required 
for both canonical assembly in G1 phase as well as for premature assembly upon 
Cdk inhibition. In addition, several residues on CENP-A itself are phosphorylated 
(Bailey et al., 2016; Yu et al., 2015; Zeitlin et al., 2001). One of these, serine 68, is 
proposed to phosphorylated by mitotic Cdk activity (Yu et al., 2015) but the 
relevance of this is being disputed (Fachinetti et al., 2017) and mutation of this 
residue does not lead to a change in the timing of CENP-A deposition. In contrast, 
mutations of phospho-residues in HJURP or artificial recruitment of M18α to 
centromeres has been reported to result in premature centromere recruitment of 
CENP-A (McKinley and Cheeseman, 2014; Müller et al., 2014). While these studies 
point to a contributing role for these factors, they leave open the critical question of 
which factors are necessary, which are sufficient, how Cdk-mediated control is 
exerted, and how key proteins are functionally inhibited. 
To resolve the specific molecular steps that ensure cell cycle restricted CENP-A 
assembly, we report full uncoupling of CENP-A assembly from the cell cycle/Cdk 
regulation. To achieve this, we identified a functional cyclin-interacting domain in 
HJURP and a critical phospho-site in M18BP1. Simultaneous uncoupling of these 
factors from cell cycle progression results in a complete reconstitution of CENP-A 
assembly process prematurely in G2 phase, prior to mitotic exit. Our results identify 
a dual inhibitory mechanism that is sufficient to maintain cell cycle restricted 
centromere propagation and define the molecular underpinnings of how assembly 
is turned on and subsequently turned off.  
Results 
HJURP is phosphorylated in a cell cycle dependent manner 
 HJURP, the CENP-A specific chaperone, is a phospho-protein and features several 
putative Cdk sites (Figure 1A and (Bailey et al., 2016; Dephoure et al., 2008; Kato et 
al., 2007; Müller et al., 2014; Wang et al., 2014), making it a prime candidate for cell 
cycle control of CENP-A assembly. To quantitatively measure HJURP 
phosphorylation we used stable isotope labeling by amino acids in cell culture 
(SILAC) coupled to mass spectrometry. This allowed us, in an unbiased manner, to 
precisely determine which residues are phosphorylated under high Cdk conditions 
and how these respond to changes in Cdk activity. Cdk1 levels differ most 
dramatically between mitosis and G1 phase. We therefore compared levels of 
phospho-peptides on the prenucleosomal GFP-CENP-A/HJURP complex between 
populations of mitotically arrested cells and cells that are released from mitotic 
arrest by Roscovitine-mediated Cdk inhibition (Figure 1B). Normal timing and 
efficiency of CENP-A assembly is preserved under these conditions (Figure S1). We 
detected 6 phosphorylated residues corresponding to putative Cdk consensus sites 
within HJURP, all of which were dephosphorylated upon mitotic exit, ranging from 
25-70% decrease relative to mitotic values (Figures 1C, S2). Although three of these 
sites (S412, S448, S473) correspond to reported phospho-sites (Müller et al., 2014; 
Wang et al., 2014), our analysis shows that these are neither the sole nor the most 
responsive sites to inactivation of Cdks, at least in mitosis. In contrast, no change is 
observed at unphosphorylated peptides of HJURP (Figure 1C) nor at Cdk-consensus 
phospho-sites on the CENP-A N-terminal tail (Bailey et al., 2013) after forced mitotic 
exit (Figure 1D), indicating that protein levels of CENP-A and HJURP remain 
unaffected (see also Figure S1F, G) and that HJURP is selectively dephosphorylated. 
The HJURP conserved domain interacts with Cyclin A and controls timing of 
CENP-A assembly 
Our findings from SILAC experiments led us to focus on HJURP in particular, and 
determine how its phospho-regulation is coupled to the control of cell cycle timing 
of CENP-A chromatin assembly. Although the canonical consensus site for Cdks is 
(S/T)PX(K/R)(Hagopian et al., 2001; Holmes and Solomon, 1996), 5 of the 6 
phospho-sites in HJURP that are affected by Cdk inactivation display a shorter 
(S/T)P motif (Figure 1A) (Errico et al., 2009). Phosphorylation of such truncated 
motifs often requires additional cyclin binding sites for enhanced substrate 
recognition (Adams et al., 1996; Russo et al., 1996). Indeed, we found a typical cyclin 
A binding RxL motif (Brown et al., 2007) within a vertebrate conserved domain (CD) 
of HJURP, which has no previously described function (Sanchez-Pulido et al., 2009). 
We tested whether HJURP interacts with cyclin A and B, the major drivers of Cdk 
activity in S/G2 phase and mitosis, respectively, all stages at which CENP-A assembly 
is inhibited (Silva et al., 2012). We performed either Cyclin B or Cyclin A co-
immunoprecipitation from HEK293T cells in which we ectopically expressed either 
GFP-tagged HJURP with a mutated RxL motif (RLL>ALA, henceforth referred to as 
HJURPAxA), or with a wild type CD. HJURP forms a homodimer (Zasadzińska et al., 
2013). To avoid cross-dimerization with endogenous HJURP, we replaced its C-
 terminal domain with that of LacI, which does not interfere with the CENP-A 
chaperoning and assembly activity of HJURP, as described (Zasadzińska et al., 2013) 
(henceforth named HJURP-ΔCLacI). Cyclin A robustly co-immunoprecipitated GFP-
tagged HJURP-ΔCLacI (Figure 1E and supplemental Figure S3A). In contrast, GFP-
HJURPAxA-ΔCLacI pulldown was reduced by 70% compared to HJURP-ΔCLacI, 
carrying a wild type CD (Figure 1F). Mitotically enriched cells (low cyclin A) were 
used as a control to demonstrate that HJURP pulldown is cyclin A dependent. 
Consistent with the fact that inhibition of CENP-A assembly is maintained in mitosis 
(Jansen et al., 2007), even though cyclin A is degraded in early mitosis (den Elzen 
and Pines, 2001; Geley et al., 2001), we find that like cyclin A, cyclin B can interact 
with HJURP (Figure S3B). However, this interaction is not dependent on an intact 
CD within HJURP, indicating inhibitory control in mitosis is exerted through a 
different mechanism.  
Our mapping of the principal cyclin A interaction site on HJURP allowed us to 
determine the consequences of the loss of this interaction for the timing of its 
localization along the cell cycle. Upon removal of soluble HJURP by pre-extraction 
we revealed that the stably chromatin bound, pre-mitotic HJURP-ΔCLacI is enriched 
in nucleoli [as observed previously (Dunleavy et al., 2009)]. In contrast, HJURPAxA-
ΔCLacI targeted to centromeres prematurely in G2 phase, the time of the cell cycle 
in which cyclin A is the principal cyclin (Figure 2A). In addition, we analyzed CENP-
A deposition using a SNAP tag-based, fluorescent quench-chase-pulse labeling 
protocol that we described previously (Figure 2B)(Bodor et al., 2012; Silva et al., 
2012). Remarkably, expression of the cyclin A binding mutant of HJURP, but not its 
wild type counterpart resulted in a precocious deposition of nascent CENP-A in G2 
phase. We performed these experiments using HJURP-ΔCLacI to force 
homodimerization of HJURPAxA. In this way, we show that HJURPAxA itself is a 
functional assembly factor, independent of wildtype HJURP copies. Consistent with 
this, downregulation of endogenous HJURP showed no effect on either efficiency or 
frequency of premature CENP-A loading following GFP-HJURPAxA–ΔCLacI 
expression (Figure S4A, B). Either GFP-HJURPAxA–ΔCLacI (Figure 2B) or GFP-
HJURPAxA (carrying the endogenous C-terminal HJURP dimerization domain) 
(Figure 2B´´, S4C) expression result in a similar level of precocious deposition of 
CENP-A demonstrating that uncoupling is not an artifact of LacI mediated 
dimerization. Quantitative analysis showed that precocious CENP-A assembly at the 
centromere reached ~40% of G1 levels (Figure 2B, see also S4D)[i.e. 20% assembly 
per centromere, considering the replicated state of sister centromeres in G2 phase, 
unresolvable by microscopy]. We conclude that the CD of HJURP is a cell cycle 
control element that interacts with cyclin A. Disruption of this site is sufficient to 
alleviate at least part of the Cdk-mediated inhibition of HJURP. 
Cdk activity controls HJURP localization not its chaperoning activity 
 Phosphorylation of HJURP could directly interfere with its chaperoning activity, 
thereby inactivating the key function of the protein. Alternatively, it may sequester 
an otherwise active HJURP away from the centromere, preventing its untimely 
recruitment. To distinguish between these possibilities, we fused HJURP to the DNA 
binding domain of CENP-B (CBdbd)(Figure 2C). This domain binds specifically to 
centromeric α-satellite DNA and allows us to drive HJURP to centromeres in G2 
synchronized cells, while likely bearing inhibitory phosphorylation due to high Cdk 
activity. We detected nascent CENP-A-SNAP at G2 centromeres after expression of 
HJURP-CBdbd-GFP (Figure 2C, D) but not CBdbd-GFP alone, indicating centromeric 
localization of HJURP is sufficient to enable unscheduled CENP-A loading. Although 
HJURP is removed from mitotic chromatin (a process that apparently overrides the 
DNA binding activity of the CENP-B DNA binding domain), newly loaded CENP-A-
SNAP remained associated with centromeres upon entry into mitosis, suggesting it 
is assembled into centromeric nucleosomes rather than part of an HJURP-associated 
prenucleosomal complex (Figure 2C, right). Based on these results, we conclude that 
Cdk-driven phosphorylation does not interfere with HJURP chaperoning activity, 
rather it results in sequestering HJURP away from the centromere, preventing its 
untimely recruitment. 
HJURP Serine 210/211 is functionally phosphorylated in G2 phase cells 
Next, we determined whether the uncoupling of HJURP from its cell cycle control 
involves specific phosphorylation sites. Expression of HJURP in which the 6 
identified putative mitotic Cdk phospho-residues (Figure 1C) were mutated to 
alanine (either all 6 or combinations thereof) did not result in changes in the timing 
of CENP-A assembly (Figure S5B), despite previous reports implicating three of 
these residues [S412, S448, and S472 (Müller et al., 2014)]. Because we observe pre-
mature CENP-A assembly in G2 phase during which cyclin A is the major cyclin, we 
aimed to identify additional, potentially relevant, phospho-residues in this cell cycle 
window. We expressed Doxycycline (Dox) inducible 3xFlag-HJURP-∆CLacI or 
3xFlag-HJURPAxA-∆CLacI in G2 phase enriched HeLa HILO cells (Khandelia et al., 
2011)[Figure 3A, B (see also section below)]. Following 3xFlag-HJURP-∆CLacI 
immunoprecipitation, TiO2 phospho-enrichment and mass spectrometry (Figure 
3C), we identified S210/S211 phosphopeptides (the proximity of these residues 
prevented us from differentiating S210 vs. S211 as the site of phosphorylation). 
These phosphopeptides were not detected in mitotically synchronized cells (Figure 
1C), suggesting differential phosphorylation of HJURP, consistent with our finding 
that cyclin B also interacts with HJURP but in a CD-independent manner (Figure 
S3B). Further, we found S412 to be the only common phospho-residue between G2 
and mitotically synchronized cells (Figure 3F). Importantly, the relative abundance 
of S210/S211 phospho-peptides was substantially reduced on the HJURPAxA mutant 
in which cyclin A binding is reduced compared to wild type (Figure 3E). This 
suggests that the cyclin A/Cdk complex interaction with HJURP results in 
phosphorylation of this site.  
 To test the functional significance of these residues we mutated serines 210 and 211 
in combination with serine 412 and expressed HJURPS210A,S211A,S412A-∆CLacI mutants 
in G2 phase cells. Quench-chase-pulse labeling of CENP-A-SNAP showed that 
mutation of these residues to alanine results in low, but detectable levels of nascent 
CENP-A at centromeres (Figure 3G, H). This indicates that cyclin A binding to HJURP 
in G2 phase results in phosphorylation, at least on serines S210/211 and S412 and 
that these modifications contribute to preventing premature CENP-A assembly. 
HJURPAxA-induced CENP-A assembly in G2 phase is Mis18-dependent 
Although HJURPAXA is capable of inducing unscheduled CENP-A assembly, it does so 
with a relatively low efficiency and centromere specificity as compared to canonical 
G1 loading (Figure 2B´, B´´). This indicates that an additional level of cell cycle 
control exists. A candidate for this is the Mis18 complex, which includes Mis18α, 
Mis18β and the associated protein M18BP1 (Fujita et al., 2007). All subunits share a 
common localization pattern, with highly enriched and centromere specific 
localization in anaphase, followed by disappearance in mid-G1 (Fujita et al., 2007; 
Silva and Jansen, 2009). Interestingly, we found that premature, HJURPAXA driven 
CENP-A assembly in G2 phase correlates with low levels of stably expressed GFP-
Mis18α at centromeres (Figure 4A-C). Moreover, siRNA-mediated depletion of 
Mis18α leads to a loss of both canonical assembly in G1 phase as well as premature 
assembly of CENP-A in G2 phase (Figure 4D). This demonstrates that HJURPAxA-
induced assembly occurs through the canonical assembly pathway and suggests that 
the partial nature of this assembly is possibly due to low levels of Mis18 complex 
members at G2 centromeres. 
Recruitment of the Mis18 complex to the centromere is controlled by 
phosphorylation of M18BP1T653 
Previously, we reported that a phospho-dead M18BP1 mutant in which 24 known 
phospho-sites are mutated to alanine, resulted in its premature centromere 
targeting (Silva et al., 2012), suggesting that at least one of these sites is regulated 
by Cdks. We now identified four putative Cdk motifs that are highly conserved 
among vertebrates, three of which are clustered close to the N-terminus of M18BP1 
(T4, T40 and S110), while a fourth (T653) is located between the highly conserved 
SANTA and SANT domains (Maddox et al., 2007) (Figure 5A). Mutation of all 4 sites 
to alanine leads to a loss of cell cycle controlled localization of M18BP1 (Figure S6A). 
Interestingly, mutation of T653 alone was sufficient to result in premature 
centromere targeting of M18BP1 with a ~3-fold increase in centromeric levels 
relative to wild type protein (Figure 5B). We generated a phospho- and site-specific 
antibody against the T653 site and show that pT653 levels rise as cells accumulate 
in S/G2 and mitosis, correlating with increasing levels of Cdk1 and 2 activities 
(Figure 5C). A brief treatment with Cdk1/2 inhibitor of cells expressing GFP-
 M18BP1 caused a strong reduction in phosphorylation of T653, suggesting that 
M18BP1 is a direct target of these kinases (Figure 5D). 
Further, the M18BP1T653A mutant co-recruited Mis18α to G2 centromeres, indicative 
of ongoing Mis18 complex formation independent of T653 phosphorylation (Figure 
S6B). An N-terminal 490 amino acid fragment of M18BP1 was reported to be 
functional in supporting CENP-A assembly in G1 phase (McKinley and Cheeseman, 
2014), consistent with our finding that mutation of the T653 residue does not 
abrogate M18BP1 localization, but we now add that this residue controls cell cycle 
dependent localization. To test whether M18BP1 phosphorylation of T653 results 
in disruption of the Mis18α interaction, we expressed a translational fusion of wild 
type or mutant M18BP1 to the CBdbd in cells synchronized in G2 phase (analogous 
to artificial HJURP tethering, Figure 2C). Forced recruitment of M18BP1 to 
centromeres leads to strong co-recruitment of Mis18α to G2 centromeres, 
suggesting that the Mis18 complex can form under inhibitory Cdk activity, at least 
at this stage in the cell cycle (Figure S6C), although not in mitosis as observed 
previously (McKinley and Cheeseman, 2014). Similarly, forced recruitment of a 
phosphomimetic M18BP1T653D (Figure S6C) or M18BP1T653E (not shown) mutant is 
capable of co-recruitment of Mis18α. Thus, we find that mutation of the T653 
residue does not disrupt the M18BP1/Mis18α interaction. Rather, its 
phosphorylation prevents centromere targeting of the Mis18 complex in G2 phase 
until mitotic exit when Cdk1/2 activities are low. 
Cdk-mediated control of M18BP1 and HJURP is sufficient to ensure tight cell 
cycle timing of centromere propagation 
Our results indicate that centromere localization of both HJURP and M18BP1 is 
blocked by Cdk-mediated phosphorylation, suggesting that combined phospho-
control of these protein complexes contributes to cell cycle specific loading of CENP-
A. To directly test this, we constructed HeLa HILO cells expressing equal levels of 
either HJURP-ΔCLacI or HJURPAxA-ΔCLacI (Figure S7A) under the control of a 
doxycycline-inducible promoter at a defined locus using recombination-mediated 
cassette exchange (RMCE)(Khandelia et al., 2011). HJURP induction was performed 
either in cells stably expressing GFP-tagged M18BP1T653A or expressing endogenous 
M18BP1 along with CENP-A-SNAP to assay for CENP-A assembly (Figure 6A). We 
compared the efficiency of G2 phase loading to the normal level of assembly in G1 
phase. CENP-A assembly in uninduced control G1 cells was equal across all cell lines 
and essentially completed at the time of fixation (Figure S7B, C, respectively). As 
observed after transient expression, induction of HJURPAxA alone resulted in low 
levels (~20% of G1, when corrected for centromere replication in G2 phase) of 
CENP-A assembly (Figure 6B, C, S7D). Force expression of otherwise wild type but 
GFP-tagged M18BP1 does not enhance the degree of premature CENP-A assembly 
(Figure S7E, E´). Conversely, constitutive M18BP1T653A expression led to infrequent 
and inefficient recruitment of nascent CENP-A to G2 centromeres (Figure 6C). 
 Remarkably, induction of HJURPAxA combined with stably expressed M18BP1T653A 
resulted in highly efficient and centromere restricted CENP-A assembly in G2 phase, 
reaching 93% of G1 control levels (Figure 6C). In sum, while disrupting the timing 
of centromere targeting of either HJURP or M18BP1 results in a limited deregulation 
of CENP-A assembly, as has been shown previously (McKinley and Cheeseman, 
2014; Müller et al., 2014), we now show that simultaneous uncoupling of both of 
these proteins leads to full-fledged CENP-A assembly, indistinguishable from 
canonical G1 phase assembly. These findings strongly suggest that M18BP1 and 
HJURP are the two principal targets of Cdk-mediated inhibition. 
Efficient CENP-A assembly requires displacement of M18BP1 from the 
centromere 
During the course of these experiments, we observed that induction of CENP-A 
assembly in G2 phase resulted in concomitant loss of centromeric GFP-M18BP1T653A 
levels to under 30%, on average, relative to the uninduced control (Figure 6C, D). 
Expression of HJURPAxA-ΔCLacI, but not wild-type HJURP results in GFP-
M18BP1T653A loss, showing that displacement is directly dependent on CENP-A 
assembly. This suggests that M18BP1 removal is an active, CENP-A loading-
dependent process and not a passive consequence of cell cycle progression. To test 
this directly in G1 cells, we either over-expressed wild type M18BP1 or artificially 
tethered it to G1 centromeres (using the CBdbd tether) while measuring nascent 
CENP-A chromatin assembly (Figure 7A, B). We observe a ~40% reduction in 
nascent CENP-A fluorescent intensities in either of these conditions (Figure 7C). We 
conclude that while M18BP1 is an essential positive regulator of CENP-A assembly, 
preventing its turnover by overexpression or by rendering it unable to be removed 
from G1 centromeres results in defects in CENP-A assembly. 
Discussion 
We have identified the licensing factor M18BP1 and the CENP-A chaperone HJURP 
as the two key targets of Cdk-based inhibition sufficient for maintenance of strict 
cell cycle control of CENP-A assembly (Figure 7D). However, we do not exclude that 
additional levels of regulation exists, e.g. in chromatin maturation steps or in mitotic 
inhibition (which we find to be controlled in a distinct manner from G2 phase). 
Inhibition of CENP-A assembly prior to mitosis at the level of HJURP or M18BP1 
alone is incomplete. This is in agreement with previous studies that showed that 
mutation of HJURP phospho-sites within the HJURP C-Terminal Domain 1 
(HCTD1)(Müller et al., 2014) or forced recruitment of Mis18α resulted in precocious 
CENP-A assembly (McKinley and Cheeseman, 2014). We note that in our system, 
mutation of the HCTD1 phosphosites did not result in precocious CENP-A assembly 
(Figure S5B). This discrepancy is likely the result of expression level differences 
between the cell types used in each study [Figure S5C and (Bodor et al., 2014)]. 
 We provide evidence that the primary mechanism of Cdk-mediated inhibition is to 
prevent, otherwise active, factors from reaching the centromere (Figures 2C, S6B, C 
and 7D). We propose that phosphorylation blocks the ability of M18BP1 and HJURP 
to bind to a partner(s) already docked at the centromere. M18BP1 interacts with 
CENP-C which is a constitutive core component of the centromere (Dambacher et 
al., 2012; Hori et al., 2013; Moree et al., 2011; Nardi et al., 2016; Stellfox et al., 2016). 
In turn, the prenucleosomal HJURP/CENP-A complex binds to the Mis18 complex 
(Nardi et al., 2016; Wang et al., 2014). Our proposal is consistent with a recent report 
describing an interaction between HJURP and the Mis18 complex subunit Mis18β, 
that is reduced upon Cdk phosphorylation, in vitro (Wang et al., 2014). 
Recent studies have reported cell cycle regulated phosphorylation of CENP-A itself 
(Yu et al., 2015) or Plk1-mediated modification of M18BP1 (McKinley and 
Cheeseman, 2014). While, the latter is required for Mis18 complex localization upon 
mitotic exit, none of these modifications directly dictates the G1 restricted CENP-A 
assembly. Therefore, while key positive regulatory events also involve phospho-
regulation (which may include some of the novel phosphorylation sites that we 
identified on HJURP), we defined the specific targets and mechanisms of the 
inhibitory control that is responsible for limiting CENP-A assembly to G1 phase. 
Rather than relying on a single tightly regulated factor, the combinatorial action of 
two layers of control synergizes to efficiently restrict CENP-A assembly to early G1 
phase.  
The designation of the Mis18 complex as a priming (licensing) factor was originally 
inspired by its temporal centromere localization that initiates in anaphase, before 
the onset of CENP-A assembly (Fujita et al., 2007). This is analogous to licensing of 
DNA replication by the assembly of the pre-replication complex (pre-RC) in early G1 
phase (Nishitani and Lygerou, 2002), the S-phase removal of which ensures a single 
round of genome duplication per cell cycle (Blow and Dutta, 2005; Blow and 
Hodgson, 2002). Analogously, we find that removal of M18BP1 from the centromere 
is directly coupled to the onset of CENP-A deposition, at least under induced 
conditions in G2 phase, providing a causal link between efficient CENP-A assembly 
and M18BP1 displacement from the centromere.  
These results reveal novel parallels between DNA replication and CENP-A-
chromatin, manifested in consumption of the licensing factor which is directly 
instigated by the start of duplication of the heritable mark. These findings are 
consistent with a recent study showing that nascent CENP-A/HJURP binding to the 
Mis18 complex in vitro leads to the disassembly of this complex (Nardi et al., 2016), 
suggesting that Mis18 complex disassembly could be a mechanism to turn off CENP-
A chromatin assembly. We show that not only does CENP-A assembly result in Mis18 
complex removal (as shown by (Nardi et al., 2016)) but that this is a requirement 
for efficient loading of CENP-A. Two possible implications follow from these 
observations. First, while M18BP1 is required for recruitment of nascent CENP-A to 
 centromeres, its presence may physically block completion of the assembly process. 
By direct binding to CENP-C (Dambacher et al., 2012; Moree et al., 2011; Shono et 
al., 2015; Westhorpe et al., 2015) which in turn interacts with CENP-A (Falk et al., 
2015; Guse et al., 2011; Kato et al., 2013; Logsdon et al., 2015), it is possibly that 
M18BP1 physically marks the site of incorporation for nascent CENP-A. Inability to 
remove M18BP1 would therefore provoke steric inhibition, resulting in low rates of 
CENP-A incorporation. Secondly, given the key role in initiation of CENP-A loading, 
removal of M18BP1 from centromeres provides an ´´OFF´´ switch for the process of 
assembly, thereby contributing to a tight cell cycle window ensuring a single round 
of CENP-A incorporation per cell cycle. 
Experimental Procedures 
Cell synchronization  
Double Thymidine-based synchronization was performed as described (Bodor et al., 
2012). For Mitotic synchronization, 2,4 µM of EG5 inhibitor III Dimethylenastron-
DMEIII (Calbiochem) was used for 24h. For synchronous mitotic exit, following 
DMEIII washout, HeLa and Hek293T were released for 5h and 7h, respectively. For 
Figure 2C, Nocodazole was used at 100ng/ml.  
Co-Immunoprecipitation 
HEK293T cells were transiently transfected with GFP-tagged constructs. 24h post-
transfection cells were either allowed to continue to cycle or were treated overnight 
in DME III to induce mitotic arrest. Cells were harvested 48h post-transfection and 
subjected to cyclin A or B immunoprecipitation (See also supplemental 
experimental procedures). Isolated complexes were separated by SDS-PAGE 
followed by immunoblotting with anti-Cyclin A, (Figure 1E) or anti-Cyclin B (both 
Santa Cruz) (Figure S3B) and anti-GFP (Chromotek) antibodies and detected on an 
Odyssey near-infrared scanner and quantified using the Odyssey software (see also 
(Bodor et al., 2014)). 
SILAC and affinity purification of prenucleosomal HJURP/CENP-A/H4 complex 
SILAC labeling medium was supplemented with normal lysine and arginine (Sigma-
Aldrich) for “light” medium, and 50 mg/ L 13C6,15N2-lysine and 50 mg/L 13C6,15N4-
arginine (Silantes) for “heavy” medium (See also supplemental experimental 
procedures). Two parallel cultures of previously characterized HeLaS3 cells stably 
expressing (LAP)-tagged CENP-A (Bailey et al., 2013) were grown in either heavy or 
light medium until reaching ~98% labeling efficiency. To enrich for mitotic cells, 
both cultures were treated with 50 µM S-trityl-L-cysteine for 17 h. Subsequently, the 
"light" cells were treated with 100 µM R-Roscovitine (AdipoGen) for 30 min while 
the "heavy" cells were mock-treated with DMSO. Affinity purification of the 
prenucleosomal HJURP/CENP-A/H4 complexes from 1:1 mixed “light" and "heavy" 
 cells was performed as previously described (Bailey et al., 2013) except that protein 
elution was performed with 2% SDS and heating at 95°C. 
Mass spectrometry and data analysis 
Purified CENP-A and associated proteins were precipitated, washed and dried. 
Following reconstitution, proteins we cleaved with trypsin and phosphopeptides 
were enriched by TiO2 prior to mass spec analysis (See supplemental experimental 
procedures for details). Extracted-ion chromatograms (XICs) of each light and heavy 
peptide pair were used for quantification. L/H ratio represents the ratio of total area 
under each elution peak. 
Affinity purification of 3XFlag-HJURPwt/AxA-ΔCLacI and Mass spectrometry 
HeLa HILO RMCE cell lines carrying either 3XFlag-HJURP-ΔCLacI or 3xFlag-
HJURPAxA-ΔCLacI were enriched in G2 phase as described (see cell synchronization) 
and induced with 10µg/ml of Doxycycline (Sigma) for 24h. HJURP was affinity 
purified using anti-Flag M2 mouse agarose beads (Sigma-Aldrich) as described (see 
Co-Immunoprecitation), followed by SDS-PAGE separation of bound complexes, 
staining (by Instant Blue, Expedeon) and subsequent HJURP band excision, in-gel 
trypsin digestion and phosphopeptide enrichment by TiO2. Samples were run on a 
Q Exactive mass spectrometer coupled with Easy nLC 1000 HPLC. MaxQuant was 
used to search the human protein database and identify peptide sequences and 
extract their ion chromatograms. 
SNAP Quench-Chase-Pulse Labeling 
Cell lines expressing CENP-A-SNAP were pulse labeled as previously described 
(Bodor et al., 2012), with exception of HeLa HILO derived cell lines where BTP (New 
England Biolabs) concentration was adjusted to 0,5 μM. 
Immunofluorescence and pre-extraction procedure 
Procedures are essentially as described (Bodor et al., 2012) (See also supplemental 
experimental procedures). To detect GFP-HJURPAxA-ΔCLacI on G2 centromeres, 
HeLa CENP-A-SNAP cells transiently expressing the construct were pre-extracted 
for 5min prior to fixation. Cells were counterstained using anti-CENP-T (Barnhart et 
al., 2011) and anti-Aurora B (1:100; BD transduction laboratories). GFP-HJURPAxA-
ΔCLacI signal was amplified using GFP-Booster Atto488 (Chromotek). 
Microscopy 
Imaging was performed using a DeltaVision Core system (Applied Precision) 
inverted microscope (Olympus, IX-71), coupled to a Cascade2 EMCCD camera 
(Photometrics). Images (1024x1024) were acquired at 1 x binning using a 100x oil 
objective (NA 1.40, UPlanSApo) with 0, 2 μm z sections. 
 Supplemental information 
Supplemental Information includes Supplemental Experimental Procedures and 8 
figures that can be found with this article online at XX. 
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 Figure 1. HJURP is phosphorylated in a Cdk-dependent manner and interacts 
with cyclin A (related to Figures S1 and S2) 
(A) Schematic representation of HJURP protein (Scm3: CENP-A binding domain; 
CD: Conserved Domain (CD), HCTD: (HJURP C-Terminal Domain). Position of 
phospho-sites identified by SILAC in C are indicated. Amino acid sequences flanking 
phospho-sites are annotated in grey. 
(B) Schematic of SILAC experiment (see supplemental experimental procedures 
for details). Light cells were released into G1 by Roscovitine treatment for 30 min. 
At this stage HJURP is partially dephosphorylated (See Figure S1F, G). 
(C) The L/H ratios of phosphorylated Cdk sites detected on endogenous HJURP are 
listed. A representative non-phosphorylated peptide (Np) is shown as internal 
control. Note: pS595 was detected on two independent peptides. 
(D) L/H ratios of Cdk consensus sites within the N-terminal tail of CENP-A (See 
Figure S2 for data from two additional replicate experiments). 
(E) HJURP CD mediates interaction with Cyclin A. (Top) Schematic representation of 
HJURP protein. Mutation of conserved RxL motif to AxA is annotated with black 
arrow. Experiments are performed with an HJURP construct in which the C-terminal 
homodimerization domain is replaced with that of LacI to prevent dimerization with 
wild type HJURP. (Bottom) co-IP of extracts expressing indicated constructs, either 
from asynchronous or mitotically enriched cells. Bound complexes were separated 
using SDS-PAGE followed by immunoblotting with indicated antibodies. 
(F) Quantification of IP experiments. GFP signal from each IP was normalized to 
corresponding cyclin A signal and input GFP signal in order to control for IP 
efficiency and GFP fusion protein expression level, respectively. GFP-HJURP signals 
were set to 1. Error bars indicate SEM (standard error of mean) from 3 independent 
experiments.  
Figure 2. Timing of HJURP targeting and CENP-A deposition is controlled by 
HJURP CD. (related to Figure S3 and S4) 
(A) HeLa CENP-A-SNAP cells were transiently transfected with indicated constructs 
and Thymidine synchronized to enrich cells in G2 phase. Cells were permeabilized 
prior to fixation and counterstained for Aurora B, CENP-T and DAPI to distinguish 
between G2 and early G1 cell cycle phases, centromere localization and DNA, 
respectively. GFP booster was used to amplify GFP-HJURP fluorescent signal. 
(B) Experiments were performed as in Figure 2A except here CENP-A assembly was 
assayed using SNAP TMR-labeling of its S phase synthesized pool. Following fixation, 
cells were counterstained for cyclin B and DAPI to indicate G2 status and DNA, 
respectively. (See Figure S4C for extended analysis of GFP-HJURP and GFP-HJURPAxA 
induced assembly). 
  (B´) Left: Quantification of frequency of premature CENP-A loading in Cyclin B 
positive cells expressing GFP-HJURPAxA-ΔCLacI. Right: Quantification of CENP-A-
SNAP (TMR) fluorescent signal intensities of cells from experiment on the left in G2 
phase (Cyclin B positive) and G1 phase (Cyclin B negative), using CENP-T signal as a 
centromere reference (not depicted). Centromeric CENP-A-SNAP fluorescent 
signals were normalized to average of G1 cells signals in each experiment (not 
considering the difference in replicated sister G2 centromeres vs. segregated G1 
centromeres). 3 replicates, error bars indicate SEM. 
(B``) Left: Quantification of frequency of premature CENP-A loading in Cyclin B 
positive cells expressing GFP-HJURPAxA from 3 replicate experiments (see Figure 
S4C for images). Right: Quantification of CENP-A-SNAP (TMR) fluorescent signal 
intensities from the same experiment. 
(C) Top: Schematic of relevant domains in centromere targeted HJURP. Bottom: 
HeLa CENP-A-SNAP cells were transfected with indicated constructs. 7 hours post 
Thymidine release cells were either fixed in G2 phase or collected in Nocodazole to 
enrich for mitotic cells. Cells were counterstained for cyclin B and DAPI to indicate 
G2 status and DNA, respectively. 
(D) Quantification of frequency of premature CENP-A-SNAP deposition in Cyclin B 
positive cells, driven by expression of Cbdb-HJURP-GFP. Error bars indicate SEM. 
Figure 3. HJURP Serine 210/211 is functionally phosphorylated in G2 phase 
cells. (related to Figure S5)  
(A) Schematic of cell lines used for a label free mass spec analysis. 
(B) HeLa HILO cells carrying indicated Doxycycline-inducible HJURP constructs 
were enriched in G2 cells by Thymidine arrest and release during Dox induction. 
(C) Cell pellets obtained from experiment in (B) were subjected to 
immunoprecipitation using Flag-coupled agarose beads to isolate 3xFlag-HJURP-
∆CLacI, separated on SDS-PAGE followed by Coomassie-based excision of HJURP 
proteins. Purified proteins were subjected to trypsin digestion, phosho-peptide 
enrichment, followed by LC-MS/MS analysis. 
(D) Mass spectra of a representative non-phosphorylated HJURP peptide from the 
flow through of the phospho-enrichment, of samples from cells containing WT 
HJURP-∆CLacI (top) and HJURPAxA -∆CLacI (bottom). 
(E) Mass spectra of the phosphopeptide containing pS210/pS211, from the elution 
of the phospho-enrichment from cells expressing indicated constructs. Because the 
two serines are adjacent, it was not possible to differentiate between S210 and S211 
as the site of phosphorylation. 
 (F) Schematic representation of Cdk-consensus phospho-sites detected on HJURP in 
G2 phase. 
(G) Experiment analogous to Figure 2A assaying indicated HJURP constructs for 
localization and CENP-A assembly in G2 phase. 
(H) Representative images of cells from experiment in (G). CENP-A assembly was 
assayed using SNAP TMR-labeling of its S phase synthesized pool. Following fixation, 
cells were counterstained for cyclin B and DAPI to indicate G2 status and DNA, 
respectively. 
(H´) Left: Quantification of frequency of premature CENP-A loading in Cyclin B 
positive cells expressing indicated constructs from 3 replicate experiments. Right: 
Quantification of CENP-A-SNAP (TMR) fluorescent signal intensities. 
Figure 4. HJURPAxA induced CENP-A assembly is Mis18α dependent. 
(A) Stable GFP-Mis18α, CENP-A-SNAP double transgenic HeLa cells were 
transfected with untagged HJURPAxA, synchronized and assayed for nascent CENP-A 
assembly by SNAP quench-chase-pulse labeling, followed by immunostaining for 
cyclin B and DAPI to indicate G2 status and DNA, respectively. 
(B) Representative images of experiment described in (A). 
(C) Quantification of frequency of CENP-A (TMR) positive G2 centromeres of 
experiment described in (A). Cells were scored in relation to whether GFP-M18α 
(green) or CENP-T (red) signals are simultaneously detected together with CENP-A 
(TMR) or not. 
(D) Top: Scheme outlining RNAi against Mis18α or GAPDH, synchronization and 
Quench-Chase-Pulse labeling of CENP-A-SNAP, GFP-Mis18α cells. (Bottom) 
Quantification of CENP-A-SNAP (TMR) positive cells from 3 independent 
experiments. Error bars indicate SEM. 
Figure 5. Cdk-mediated T653 phosphorylation of M18BP1 controls its 
centromere recruitment (related to Figure S6). 
(A) M18BP1 T653 is conserved amongst vertebrates. Left: Schematic of M18BP1 
protein. Relevant domains and conserved Cdk sites are indicated. Right: 
Conservation of human T653 residue across species. Conserved Threonine or Serine 
is highlighted in grey. 
(B) T653 residue controls cell cycle-dependent M18BP1 centromere recruitment. 
Indicated constructs were transfected into asynchronous HeLa cells 48hr prior to 
fixation, followed by counterstaining for cyclin B, CENP-T and DAPI to indicate G2 
status, centromeres and DNA, respectively.  
 (B´) Average centromeric GFP fluorescent signals from Cyclin B positive cells were 
determined using the Centromere Recognition and Quantification (CRaQ) method 
(Bodor et al., 2012) and normalized to GFP-M18BP1. Error bars indicate standard 
error of the mean (SEM) from 3 replicates. 
(C) T653 is phosphorylated in a cell cycle dependent manner. Hek293T cells were 
transiently transfected with GFP-Mis18BP1 (WT) or GFP-Mis18BP1T653A as a non-
phosphorylatable control. 24h later, cells were synchronized in indicated cell cycle 
stages and lysed. Extracts were either left untreated or treated with lambda 
phosphatase, separated by SDS-PAGE followed by immunoblotting with indicated 
antibodies (see also supplemental experimental procedures). Apparent molecular 
weight is indicated. Cells were assayed for cell cycle position by FACS using 
propidium iodide (PI) to indicated DNA content. 
(D) T653 is phosphorylated by Cdk1/2. Hek293T cells were transiently transfected 
with GFP-Mis18BP1 and enriched in G2 phase by a single thymidine block followed 
by 7h of release. 30min before fixation, cell were treated with 100µM Roscovitine. 
Extracts were separated by SDS-PAGE followed by immunoblotting with anti-GFP 
and anti-pT653 antibodies. 
Figure 6. A dual inhibitory mechanism restricts CENP-A deposition to G1 phase 
(related to Figure S7). 
(A) Schematic representation of Hela HILO cells carrying low levels of constitutively 
expressed CENP-A-SNAP (red), with or without stable expression of GFP 
M18BP1T653A (green) along with Doxycycline-inducible 3xFlag-HJURP-ΔCLacI (blue) 
or 3xFlag-HJURPAxA-ΔCLacI (purple). Cells were processes as indicated in the 
scheme.  
(B) Representative images of the experiment described above. Following fixation, 
cells were counterstained for CENP-T and DAPI to indicate centromeres and DNA, 
respectively. Cell cycle status was determined by measuring total DAPI area (see 
supplemental experimental procedures). 
(C) Quantification of CENP-A-SNAP fluorescent signals from (B). Average CENP-A-
SNAP signals from G2 centromeres were normalized to respective G1 centromeres 
and corrected for centromere number (assuming signal intensity per focus 
represents 1 and 2 centromeres in G1 and G2, respectively). Error bars indicate SEM 
of 4 independent experiments. 
(D) CENP-A assembly drives M18BP1 displacement from centromeres. 
Quantification of centromeric GFP-M18BP1T653A fluorescent signals from (B) using 
CRaQ method. Average GFP-M18BP1T653A signals were normalized to uninduced 
3xFlag-HJURP-ΔCLacI expressing cells. Error bars indicate SEM of 4 independent 
experiments. 
 Figure 7. M18BP1 removal from G1 centromeres is necessary for efficient 
canonical CENP-A assembly  
(A) HeLa CENP-A-SNAP cells were transfected with indicated constructs, and 
synchronized in mitosis by an overnight treatment with Eg5 inhibitor (DMEIII). 
Newly synthesized CENP-A pool was quenched in mitosis, followed by 5h of release 
in early G1 when nascent CENP-A-SNAP was labeled with TMR (G1 specific pool). 
(B) Schematic of relevant domains in centromere targeted M18BP1. 
(C) GFP positive cells were selected and CENP-A TMR fluorescent intensities were 
determined using CRaQ, with the exception of the untransfected control where all 
cell were analyzed. 
(D) Model summarizing the key molecular steps that are sufficient to restrict CENP-
A assembly to G1 phase. CD: HJURP vertebrate conserved domain. 
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Figure S1. (supplement to Figure 1) Conditions used for SILAC analysis are 
permissive for CENP-A deposition. 
(A) To enrich for mitotic phase, HeLa CENP-A-SNAP cells were treated with Eg5 inhibitor 
(STLC) for 24h. 17h into mitotic arrest, pre-existing CENP-A-SNAP pool was quenched with 
BTP, followed by 7h of chase. 30min before pulse labeling of newly synthesized pool of 
CENP-A-SNAP and fixation, cells were treated either with Roscovitine or DMSO. 
(B) Quantification of frequencies of Cyclin B positive (G2 and mitotic) cells and Cyclin B 
negative (tetraploid cells which exited mitosis without cytokinesis due to Cdk1 inhibition, 
see panel D, E) in the experiment described in (A). 
(C) Quantification of frequencies of CENP-A-SNAP (TMR) positive cells in each cell cycle 
stage present. Cells arrested in mitosis do not assemble CENP-A (left bar). Degree of CENP-
A assembly in either G2 or G1 cells is assayed following Roscovitine treatment. 
(D) Representative images of Roscovitine-treated cells in experiment described in (A). Cells 
were counterstained with Cyclin B, CENP-T and DAPI to indicate cell cycle status, 
centromeres and DNA respectively. 
(E) Distribution of number of centromeres under experimental conditions described in (A). 
Doubling of centromere number indicates formation of tetraploid cells due to forced 
mitotic exit in the presence of STLC and Roscovitine. 
(F) Western blots for the mitotic marker H3pS10 indicating cell cycle position of HeLa S3 
cells used in SILAC experiment in Figure 1. Cells were arrested in mitosis with the Eg5 
inhibitor STLC followed by treatment with DMSO control or Roscovitine (light cells) to 
force mitotic exit caused by Cdk inhibition. 
(G) Western blots for HJURP (isolated from soluble fraction) from HeLaS3 cells showing 
dephosphorylation (as seen by shift in SDS-PAGE mobility of phosphorylated HJURP) upon 
Roscovitine treatment of "light" cells. Based on this, we harvested cells after 30 min of 
Roscovitine (or DMSO) treatment, balancing between HJURP dephosphorylation and 
completion of HJURP-mediated centromeric chromatin assembly. 
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 (Roscovitine-treated)/(Mock-treated) 
Ratio 
Phospho-site(s) 
covered Phosphopeptide 
Experiment 
#1 (Forward 
labeling) 
Experiment 
#2 
(Reverse 
labeling) 
Experiment 
#3 
(Reverse 
labeling) 
HJURP pS185 VTPLPSLApSPAVPAPGYCSR 0.32 nd 0.30 
HJURP pS412 WLIpSPVK 0.72 nd 0.62 
HJURP pS448 EYCLpSPR 0.53 nd nd 
HJURP pS473 GGPApSPGGLQGLETR 0.48 0.37 0.42 
HJURP pS595 
pSPGQMTVPLCIGVSTDK 0.23 nd 0.25 
YCLKpSPGQMTVPLCIGVSTDK 0.28 nd 0.30 
HJURP pS642 LPSpSPLGCR 0.46 0.48 0.39 
CENP-A 
pS16+pS18 
pSPpSPTPTPGPSR nd 0.93 nd 
RpSPpSPTPTPGPSR nd 1.01 nd 
RRpSPpSPTPTPGPSR 0.87 0.98 nd 
CENP-A pS16 RRpSPSPTPTPGPSR 0.94 1.13 nd 
 nd = no data 
 
Figure S2 (supplement to Figure 1) G1/Mitotic Ratios of HJURP and CENP-A 
phosphopeptides are reproducible. 
(A) Table summarizing data from three independent SILAC experiments (the data 
described in Figures 1B, are displayed in the column labeled “Experiment #1”). For the 
forward labeling experiment, the “light” cells are treated with Roscovitine while the 
“heavy” cells are mock-treated. For reverse labeling experiments, the “light” cells are mock-
treated while the “heavy” cells are treated with Roscovitine. Red residues are the sites 
where phosphate groups were unambiguously mapped. Bolded residues are the Cdk 
consensus motifs in each peptide. (nd=no data). 
(B-J) Representative chromatograms and spectra of HJURP and CENP-A phosphopeptides 
in SILAC. Extracted ion chromatograms of all phosphopeptides from Figure 1C and 1D, 
showing co-elution of phosphopeptide pairs (left panels), and representative mass spectra 
showing isotopic envelopes of light vs. heavy peptides (right panels). Phosphopeptides 
from “light” (Roscovitine-treated) cells are coloured in pink, while the phosphopeptides 
from “heavy” (mock-treated) cells are coloured in dark red. Each peptide pair is separated 
by a predictable mass difference (calculated from the number of lysines and arginines in 
the peptide), which is labeled with dotted lines between the monoisotopic peaks of light 
and heavy peptides. 
(B) A representative unphosphorylated HJURP peptide as internal control. 
(C-H) HJURP phosphopeptides. 
(I-J) CENP-A phosphopeptides. 
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Figure S3. (supplement to Figure 1) Cyclin A and Cyclin B bind to HJURP. 
(A) Top: Schematic of GFP-HJURP-ΔCLacI protein with relevant domains depicted. 
Experiments were performed with a HJURP construct in which the C-terminal 
homodimerization domain is replaced with that of LacI to prevent dimerization with wild 
type HJURP. Bottom: Raw images of a Western blot shown in Figure 1E. Upper and lower 
panels are identical except for different contrasting. 
(B) Cyclin B interacts with HJURP in mitosis independently of Conserved Domain. 
Randomly cycling HEK293T cells were transiently transfected either with GFP alone, GFP-
HJURP-ΔCLacI or GFP-HJURPAxA-ΔCLacI. 24h post-transfection cells were treated overnight 
using DME III inhibitor to induce mitotic arrest. 48h post-transfection, cells were lysed and 
Cyclin B was immunoprecipitated using Anti-Cyclin B coated beads. Bound complexes were 
separated using SDS-PAGE followed by immunoblotting with indicated antibodies (raw 
images of Westerns are shown). 
  
A Transfect
S G2
Thymidine Release
7h-24h -17h 0h
CENP-A synthesis
siRNA
-48h
HJURPAxA
-∆CLacI
HeLa CENP-A-SNAP G1
12h
Quench Pulse label
M
Figure S4
Fix G2 Fix G1
HeLa CENP-A-SNAP
Add 
Thymidine
S G2
0h-17h-40h 8h
Transfect 
Thymidine 
Release
Fix G2
Quench (BTP) Pulse label (TMR)
7hCENP-A synthesis
GF
P-
HJ
UR
P
GF
P-
HJ
UR
PA
xA
G2
Non pre-extracted
D
S G2
0h 7h-40h
Quench Pulse label
M
HeLa CENP-A-SNAP
Thymidine 
Release
Transfect dark
HJURPAxA 
CENP-A 
synthesis
Fix G2/early G1 Fix G1/S
17h
Second 
Thymidine 
Add
Thymidine 
-17h 8h
0
200
400
600
800
1000
C
EN
P-
A 
TM
R
 
flu
or
es
en
t i
nt
en
si
tie
s 
(A
U
)
Untransfected
Transfected
Ea
rly 
G1
Ea
rly 
G1
G1
/S
G1
/S
ns
p=0.3580 ns
p=0.6467
ns
p=0.2874
ns
p=0.2636
CyclinB
CENP-T
New CENP-A(TMR)
GA
PD
H 
siR
NA
HJ
UR
P 
siR
NA
10μm
GFP-HJURPAxA -∆CLacI
G1 
G2 
GA
PD
H 
siR
NA
HJ
UR
P 
siR
NA
CyclinB
CENP-T
New CENP-A(TMR)
B
C
siG
AP
DH
siH
JU
RP
C
EN
P-
A 
(T
M
R
) f
lu
or
es
ce
nt
 in
te
ns
iti
es
 (A
U
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2 G1 
All cells
0.0
0.2
0.4
0.6
0.8
1.0
1.2
C
EN
P-
A 
(T
M
R
) f
lu
or
es
ce
nt
iIn
te
ns
iti
es
 (A
U
)
%
 o
f G
2 
C
EN
P-
A 
(T
M
R
)
 p
os
iti
ve
 c
el
ls
0
10
20
30
40 G2 
siG
AP
DH
siH
JU
RP
siG
AP
DH
siH
JU
RP
G2 
B´ B´´ B´´´
D´
New CENP-A (TMR) GFPCyclinB
DAPI
10μm
GFP-HJURPAxA -∆CLacI expressing cells
Figure S4. (supplement to Figure 2) Centromeric targeting of HJURP and timing of 
CENP-A assembly is controlled by the HJURP Conserved Domain. 
(A) HeLa CENP-A-SNAP cells were treated with siRNAs against HJURP or GAPDH and 
synchronized by double thymidine arrest and release combined with SNAP quench-chase-
pulse labeling as indicated. Cells were transfected with GFP-HJURPAxA-ΔCLacI 24 hours 
prior to synchronous release into S phase. Cells were either fixed at G2 or cycled into the 
next cell cycle and collected at early G1 phase, following canonical CENP-A assembly. 
(B) Representative images of experiment described in (A). Cells were counterstained with 
Cyclin B, CENP-T and DAPI to indicate cell cycle status, centromeres and DNA respectively. 
(B´) CENP-A SNAP (TMR) fluorescent signal intensities of G1 cells are plotted in grey scale. 
Signals are normalized to siGAPDH. 
(B´´) CENP-A SNAP (TMR) fluorescent signal intensities of GFP-HJURPAxA-ΔCLacI expressing 
G2 cells are plotted in green. Signals are normalized to siGAPDH. 
(B´´´) Percentage of total G2 cell population positive for CENP-A-SNAP for indicated siRNA 
conditions were determined from 3 replicate experiments, plotted in green. All error bars 
indicate SEM. 
(C) Timing of CENP-A deposition is controlled by Conserved Domain of HJURP. Experiment 
identical to the one described in Figure 2A, B with exception of transfection with GFP-
HJURP or GFP-HJURPAxA. (i.e. wild type HJURP C-terminus instead of LacI dimerization 
domain) Following fixation, cells are counterstained for cyclin B and DAPI to indicate G2 
status, centromere localization and DNA, respectively. 
(D) The apparent partiality of HJURPAxA-induced G2 phase loading is not a consequence of 
subsequent HJURPAxA-induced overloading in G1 phase to which G2 phase signals are 
normalized. As in Figure 2A, HeLa CENP-A-SNAP cells were either transiently transfected 
for 48h with untagged HJURPAxA or left untransfected. 17h post-transfection cells were 
arrested in Thymidine for 17h followed by 7h of release, in which S phase synthesized 
CENP-A-SNAP was labeled by TMR. Subsequently, a set of cells were fixed (in this way, 
CENP-A-SNAP positive G2 and early G1 cells were obtained, as in Figure 2A, B), or 
Thymidine was re-added for additional 17h followed by fixation (this allowed for collection 
of cells arrested at G1/S phase transition). In this way, the size of pulse labeled pool of 
CENP-A-SNAP is identical between early G1 and G1/S arrested cells, but the time window 
given for CENP-A-SNAP loading is extended to the full extent of G1 phase. 
(D´) Cells from the experiment described in (D) were counterstained for Cyclin B, CENP-T 
and Tubulin, to indicate G2 status, centromeres and the presence of a mid-body (early G1), 
respectively (not shown). Fluorescent (TMR) signals from all CENP-A-SNAP positive 
centromeres of early G1 or G1/S cells from either condition (transfected or untransfected) 
were quantified using the Centromere Recognition and Quantification (CRaQ) method 
(Bodor et al., 2012). Error bars indicate SEM. P values are indicated on the graph (ns, 
Student´s t test). These results demonstrate that canonical CENP-A-SNAP loading efficiency 
is near its maximum in early G1 phase in HeLa CENP-A-SNAP cell line and is minimally 
influenced by HJURPAxA expression. 
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HJURP G2 phase CENP-A assembly 
% intensity of G1 
(% of G2 cells assembling) 
Mitotic phospho-site mutations C-terminal domain 
 endogenous ΔC-LacI 
S185A undetectable undetectable 
S185A, S412A, S448A,S473A undetectable undetectable 
S595,S642A undetectable n.a. 
S185A,S595A,S642A undetectable n.a.  
S412,S448A,S473A undetectable undetectable 
S185A,S412A,S448A,S473A,S595A,S642A undetectable n.a. 
 
G2 phospho-site mutations  
S210A/S211A/S412A ~10% (~7%) ~10% (~15%) 
S210A/S211A  undetectable undetectable 
 
Conserved domain mutation   
RxL>AxA ~30% (~25%) ~40% (~30%) 
   
Other   
RxL>AxA, S412A ~30 (~50%) n.d. 
CENP-A-SNAP-3xHA
HeL
a
HeL
a
CEN
P-A
-SN
AP
U2O
S
U2O
S
CEN
P-A
-SN
AP
Anti-CENP-A
Anti-Tubulin
37kDa
CENP-A-SNAP 30kDa
17kDa endo.CENP-A
50kDa
Figure S5. (supplement to Figure 2 and 3). Summary of premature CENP-A assembly 
phenotypes of HJURP phospho-site mutants. 
(A) Schematic representation of HJURP protein, along with previously recognized domains 
(CENP-A binding domain (Scm3), Conserved Domain (CD), HJURP C-Terminal Domain 1 
and 2 (HCTD1 and 2)) and the position of phospho-sites identified by mass spectrometry in 
mitosis (black lines; Figure 1, S2) or in G2 enriched cells (green lines; Figure 3). Amino acid 
sequences flanking phospho-sites are annotated. Position of LacI dimerization domain 
replacing the endogenous C-terminal dimerization domain is indicated. 
 
(B)  Table summarizing premature CENP-A assembly phenotypes upon expression of 
indicated mutant HJURP proteins. Experiments were performed as in Figure 2A, B. HeLa 
CENP-A-SNAP cells were transiently transfected with either GFP-HJURP or GFP-HJURP-
ΔCLacI and congenic point mutations thereof. 23h-post transfection, cell were enriched in 
G2 phase by a single Thymidine block, followed by 7h of release and subsequent fixation. 
CENP-A assembly was assayed using SNAP TMR-labeling of its S phase synthesized pool.  
Following fixation, cells were counterstained for cyclin B and DAPI to indicate G2 status 
and DNA, respectively. Efficiency of CENP-A assembly is indicated as % of G1 phase CENP-A 
intensities and % of transfected cells loading. undetectable: no centromere signals were 
discernable. n.d. not determined. n.a. not applicable. 
(C)  Western blot showing higher levels of CENP-A-SNAP transgene in U2OS cell line 
(Müller et al., 2014) compared to HeLa cell line (used in this study). Extracts of randomly 
cycling U2OS CENP-A-SNAP and HeLa CENP-A-SNAP cell lines together with respective 
parental cell lines (carrying no transgene) were separated by SDS-PAGE followed by 
immunoblotting with anti-CENP-A and anti-Tubulin antibodies. 
 
(C´) Quantification of CENP-A-SNAP band intensities of Western blot showed in (C) using 
Odyssey infrared scanner. Band intensities of CENP-A-SNAP were normalized to tubulin 
(loading control). 
(C´´) Quantification of G1 CENP-A-SNAP fluorescent intensities from HeLa CENP-A-SNAP 
and U2OS CENP-A-SNAP. Randomly cycling HeLa CENP-A-SNAP and U2OS CENP-A-SNAP 
were subjected to Quench-Chase-Pulse experiment (as in Figure 2A, B). CENP-A-SNAP 
(TMR) fluorescent signal intensities were determined using CRaQ method. 
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Figure S6. (supplement to Figure 5) Cell cycle control of M18BP1/Mis18α complex 
formation 
(A) M18BP1T4,T40,S110 triple mutant is enriched at G2 centromeres, whereas 
M18BP1T4,T40,S110,T653A quadruple mutant is strongly enriched at G2 centromeres. Constructs 
expressing M18BP1T4,T40,S110 or M18BP1T4,T40,S110,T653A were transfected into asynchronous 
HeLa cells 48hr prior to fixation, followed by counterstaining for cyclin B, CENP-T and DAPI 
to indicate G2 status, centromeres and DNA, respectively.  
(B) T653 residue in M18BP1 does not determine Mis18 complex formation. Left: 
Asynchronously cycling HeLa cells stably expressing GFP-Mis18α were transfected with 
constructs expressing RFP-M18BP1 or RFP-M18BP1T653A 48hr prior to fixation, followed by 
counterstaining for cyclin B and CENP-T to indicate G2 status and centromeres 
respectively. Right: Average centromeric GFP fluorescent signals from Cyclin B positive 
cells were determined from 3 replicate experiments. Intensities were normalized to GFP-
M18BP1. Error bars indicate standard error of the mean (SEM). 
(C) M18BP1/Mis18α complex formation is not inhibited by Cdk activity in G2 phase. 
Asynchronously cycling HeLa cells stably expressing GFP-Mis18α were transfected with 
constructs expressing RFP-M18BP1, CBdbd-RFP-M18BP1 or CBdbd-RFP-M18BP1T653D 
48hr prior to fixation, followed by counterstaining for cyclin B and CENP-T to indicate G2 
status and centromeres respectively. To enrich for mitotic stages, cells were treated with 
Nocodozole for 5h.  
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Figure S7. (supplement to Figure 6) Characterization of HeLa HILO inducible HJURP 
cell lines and CENP-A assembly dynamics. 
(A) 3xFlag-HJURP-ΔCLacI and 3xFlag-HJURPAxA-ΔCLacI proteins are induced to a similar 
extent. HeLa HILO CENP-A-SNAP, GFP-M18BP1T653A carrying tetracycline-inducible 3xFlag-
HJURP-ΔCLacI or3xFlag-HJURPAxA-ΔCLacI were synchronized by a single Thymidine block, 
and released into G2 phase. Doxycycline (Dox) was added for 2h, 5h, 8h or 24h. Following 
fixation, whole cell lysates were separated using SDS-PAGE followed by immunoblotting 
with indicated antibodies. 
 
(B) CENP-A-SNAP loading efficiency in G1 is equal in all HeLa HILO cell lines used in this 
study. Overview of HILO transgenes are shown. Uninduced HeLa HILO CENP-A-SNAP cells 
carrying indicated M18BP1 and or HJURP transgenes were synchronized by addition of 
Thymidine for 17h, followed by a release for 7h during which a nascent CENP-A-SNAP pool 
was fluorescently labeled. Cells were allowed to cycle into early G1 phase, 12h post release 
and fixed (early G1 as in Figure 6). This experimental set-up allows for labeling of an equal 
pool of nascent CENP-A-SNAP and compares the degree of assembly across cell lines used 
(conditions analogous to the ones in Figure 6).  
 
(B´) CENP-A-SNAP fluorescent intensities were quantified using CRaQ method and tested for 
statistically significant differences (ns, one-way ANOVA). Results indicate that G1 phase 
levels are similar across all cell lines used. Error bars indicate SEM.  
 
(C) CENP-A loading in G1 in 3xFlag-HJURPAxA-ΔCLacI / GFP-M18BP1T653A expressing cells as 
near its maximum in early G1 phase. Relevant transgenes are shown. Experimental condition 
is identical to (B) except that in addition to fixation in early G1 phase, a subset of cells were 
allowed to cycle through G1 and were collected at the G1/S boundary following a second 
Thymidine addition.  
 
(C´)  CENP-A-SNAP fluorescent intensities from early G1 cells and cells collected at the end 
of G1 were directly compared and tested for statistically significant differences (ns, one-way 
ANOVA). Results indicate that early and late G1 phase levels are similar. CENP-A-SNAP 
fluorescent intensities were quantified using CRaQ method. Error bars indicate SEM. P values 
are indicated on the graph (ns, Student´s t test).  
 
(D) Fraction of cells assembling CENP-A upon mutant M18BP1 and/or mutant HJURP 
expression. Data from experiment shown in Figure 6. Here the frequency of CENP-A-SNAP 
G2 centromeres is plotted as a fraction of total Flag positive cells, except for un-induced 
samples, in which the fraction of total cells was determined. Averages of 3 independent 
experiments are shown. Error bars indicate SEM.  
 (E) Over-expression of GFP-M18BP1 does not enhance HJURPAxA-driven precocious CENP-
A deposition. HeLa CENP-A-SNAP cells were enriched in G2 phase by a single Thymidine 
arrest, followed by 7 h release. 40 h prior to synchronized S phase release, cells were co-
transfected with untagged-HJURPAxA-ΔCLacI combined with either GFP-M18BP1 or GFP-
M18BP1T653A. S phase synthesized CENP-A-SNAP was pulse labeled in G2 phase to assay 
CENP-A assembly. Cells were counterstained for cyclin B and CENP-T to indicate G2 status 
and centromeres, respectively. 
(E´) Quantification of CENP-A-SNAP (TMR) fluorescent signal intensities of experiment in A. 
Average centromeric CENP-A-SNAP fluorescent signals from G2 cells (Cyclin B positive) and 
G1 cells (Cyclin B negative) were determined from 4 replicate experiments using CRaQ 
method. Signal intensities were normalized to CENP-A-SNAP in G1 cells expressing GFP-
M18BP1. Error bars indicate SEM. GFP-M18BP1 force expression in combination with 
HJURPAxA-ΔCLacI results in similar of CENP-A assembly as in the presence of endogenous 
M18BP1 levels (see also Figure 2B, B´) 
  
Supplemental Experimental Procedures 
DNA constructs 
HJURP-GFP (pLJ381) and GFP-HJURP-ΔCLacI (pLJ632) (Zasadzińska et al., 2013), in which 
amino acids 483-743 (C-terminus) were replaced by dimerization domain of LacI 
(Zasadzińska et al., 2013) were a gift from Dan Foltz (Northwestern University of Chicago). 
GFP-HJURP (pLJ380) and GFP-HJURP-ΔCLacI (pLJ632) were converted to GFP-HJURPAxA 
(pLJ600) and GFP-HJURPAxA-ΔCLacI (pLJ654) by quick exchange PCR replacing R276 and 
L278 by Alanine. GFP-HJURPS210A, S211A, S412A (pLJ828) or GFP-HJURPS210A, S211A, S412A-ΔCLacI 
(pLJ830) was made via quick exchange PCR. pLJ591, HJURP-CBdbd-GFP was created by 
PCR amplification of the first 158 N-terminal amino acids of CENP-B protein [CENP-B DNA 
binding domain (CBdbd)] and ligation to the N terminus of pLJ383 (a GFP-Mis18α 
construct). Subsequently, Mis18α was excised using EcoRI/BamHI restriction, followed by 
T4 end blunting and ligation, resulting in CBdbd-GFP vector. The CBdbd fragment was 
subsequently inserted in frame in between HJURP and GFP of pLJ381. For the creation of 
the HeLa HILO 3xFlag-HJURP-ΔCLacI /HJURPAxA-ΔCLacI inducible cell lines, the donor 
plasmid pRD-RIPE (Khandelia et al., 2011) was digested with AgeI and BsrGI to remove 
EGFP followed by insertion of the LacI dimerization domain. Next, PCR amplified 3xFlag-
HJURP-ΔC (aa 1-482) or 3xFlag HJURPAxA-ΔC (aa 1-482) was inserted into an AvaI/BsrGI 
digested vector, resulting in an in-frame fusion of 3xFlag HJURP/HJURPAxA-ΔCLacI 
(designated pLJ745 and pLJ746, respectively). GFP-M18BP1T653A (pLJ649) was created by 
quick exchange PCR using GFP-M18BP1 as a template (pLJ415 (Silva et al., 2012)). An 
analogous procedure was employed to generate GFP-M18BP1T653D (pLJ699). CBdbd-GFP-
M18BP1 (pLJ592) was generated by ligation of CBdbd fragment between GFP and M18BP1 
of the GFP-M18BP1 plasmid (pLJ415) mRFP-M18BP1T653D (pLJ705) was created by NotI 
and AfeI replacement of GFP with mRFP (from pLJ287). CBdbd-mRFP-
M18BP1/M18BP1T653D/M18BP1T653E (pLJ697, pLJ700 and pLJ642, respectively) were 
created by PCR insertion of CBdbd fragment from pLJ591 (CBdbd-GFP-HJURP) into pLJ534 
(mRFP-M18BP1) or pLJ705 (mRFP-M18BP1T653D) or pLJ641 (mRFP-M18BP1T653E). PCR 
amplified CBdbd was subsequently fused to N-terminal portion of mRFP. All plasmid 
inserts were verified by DNA sequencing. 
Cell lines and culturing conditions 
All human cell lines used were grown at 37°C, 5% CO2. Cells were grown in DMEM (Bio 
West) supplemented with 10% fetal bovine serum (FBS) (BioWest)), 2 mM glutamine, 1 
mM sodium pyruvate (SP) (Thermo Fischer Scientific), 100 U/ml penicillin, and 100 μg/ml 
streptomycin, with the exception of HeLa HILO derived cell lines in which 10% tet-free 
(BioWest) FBS was used. HeLa HILO RMCE cell lines were a gift from E.V. Makeyev, 
Nanyang Technological University, Singapore, and contain a single genomic recombination 
which allows for the insertion of a tetracycline responsive expression cassette (Khandelia 
et al., 2011). The four lines outlined in Figure 6 were assembled as follows: HeLa HILO 
RMCE clone #10 (Khandelia et al., 2011), was transfected with (pLJ649) that constitutively 
drives GFP-M18BP1T653A expression. Positive clones were selected with 500 μg/ml of 
Neomycin (Gibco). A polyclonal population was sorted based on GFP fluorescence. A single 
clone of HeLa HILO GFP-M18BP1T653A as well as the parental HILO RMCE clone #10 were 
transduced with pBABE-CENP-A-SNAP-3xHA retrovirus (pLJ718) (Bodor et al., 2012). 
Infected cells were selected by 300 μg/ml of Hygromycine (Invitrogen). Individual resistant 
cells were sorted by FACS. CENP-A-SNAP-3xHA clones #9 and #10, respectively were 
selected for further analysis. This selection was based on equal expression of CENP-A-
SNAP-3xHA between different cell lines, as determined by immunoblot using rabbit anti-
CENP-A (Cell Signaling technology) and by TMR fluorescent intensities. Both clones were 
then transfected with 2,5 ng/μl of pLJ745 and pLJ746, vectors carrying two loxP sites 
flanking the Doxycycline (Dox) inducible 3xFlag-HJURP or 3xFlag-HJURPAxA expression 
construct. Cre recombinase (Khandelia et al., 2011) was added at 1% of total DNA content. 
Positive clones were selected using 1 μg/ml of Puromycin (MERCK). Expression of 3xFlag-
HJURP/HJURPWT/AxA was induced by 10 μg/ml of Doxycycline (Sigma-Aldrich) and assayed 
for equal expression by western blot using FlagM2 antibody (Sigma-Aldrich). U2OS CENP-
A-SNAP cell lines were gift from Genevieve Almouzni (Institut Curie, France). 
DNA transfection and siRNA treatment 
Transient transfection of HeLa CENP-A-SNAP and HEK293T was performed using 
Lipofectamine LTX (Invitrogen; Carlsbad, CA) according to the manufacturer's instructions. 
All siRNAs were obtained from Dharmacon. Mis18α and HJURP were depleted as 
previously reported (Silva et al., 2012; Zasadzińska et al., 2013, respectively). 
Co-Immunoprecipitation 
HEK293T cells were transiently transfected either with GFP alone, GFP-HJURP-ΔCLacI or 
GFP-HJURPAxA-ΔCLacI. 24h post-transfection cells were either allowed to continue to cycle 
or were treated overnight in DME III to induce mitotic arrest. 48h post-transfection, 107 
cells were harvested in ice-cold PBS for 5 min at 3,200 x g and lysed in buffer containing 
3,75mM Tris pH 7,5, 20mM KCl,0,5mM EDTA, 0,1% digitonin and 0,4 µM DTT. Lysates were 
homogenized using a 27G needle, and spun at 300 x g for 5 min. This was repeated two 
times, followed by combining two supernatants and spin clarification at 10,000 x g for 15 
min. Soluble fraction was collected and KCl concentration was adjusted to 150 mM. 5μg/ml 
of anti-Cyclin A coated agarose beads (Santa Cruz Biotechnology) or anti-Cyclin B (Santa 
Cruz Biotechnology) was equilibrated in lysis buffer prior to pulldown. After 
immunoprecipitation, beads were washed once in wash buffer A (20mM HEPES, 20Mm M 
KCl, 0,4m M DTT and 0,4mM EDTA) and two times in wash buffer B (wash buffer A with 
225mM NaCl for Cyclin A pulldown, and 150mM NaCl for Cyclin B). Complexes bound to the 
beads were eluted using 2% SDS for 20 min, followed by immunoblotting with anti-Cyclin A 
(Santa Cruz) (Figure 1E) or anti-Cyclin B (Santa Cruz) (Figure S3B) and anti-GFP 
(Chromotek) antibodies. IRDye800CW-coupled anti-rat (Licor Biosciences) and 
DyLight680-coupled anti-rabbit (Rockland Immunochemicals, Gilbertsville, PA) secondary 
antibodies were used prior to detection on an Odyssey near-infrared scanner (Licor 
Biosciences, Lincoln, NE). Immunoblot signals were quantified using the Odyssey software 
(see also (Bodor et al., 2014)). GFP signal values were normalized to their respective Cyclin 
A signals and to corresponding GFP input values. 
SILAC and affinity purification of prenucleosomal HJURP/CENP-A/H4 complex 
SILAC labeling medium (MEM Eagle Joklik Modification) deficient in lysine and arginine 
was reconstituted according to manufacturer's instructions (Sigma-Aldrich), and 
supplemented with normal lysine and arginine (Sigma-Aldrich) for “light” medium, and 50 
mg/ L 13C6,15N2-lysine and 50 mg/L 13C6, 15N4-arginine (Silantes) for “heavy” medium. Both 
media were supplemented with 10% dialyzed FBS (Gemini), GlutaMax (Gibco), 1 mM 
HEPES, 1% Pen/Strep, MEM non-essential amino acids (Gibco), and 120 mg/L proline to 
prevent arginine-to-proline conversion. Two parallel cultures of previously characterized 
HeLaS3 cells stably expressing localization and purification (LAP)-tagged CENP-A (Bailey et 
al., 2013) were cultured in spinner flasks for at least 6 cell doublings to allow full 
incorporation of the stable isotope-containing amino acids. Heavy isotope labeling 
efficiency of ~98% was confirmed by mass spectrometry after trypsin digestion of proteins 
extracted from heavy-labeled cells. To enrich for mitotic cells, both cultures were treated 
with 50 µM S-trityl-L-cysteine for 17 h. Subsequently, the "light" cells were treated with 
100 µM R-Roscovitine (AdipoGen) for 30 min while the "heavy" cells were mock-treated 
with DMSO. Cell cycle status and HJURP phospho-status was monitored by immunoblotting 
for H3pS10 (Upstate) and an anti-HJURP antibody generated against a C-terminal fragment 
(1 µg/ml) (Bassett et al., 2012, Dev Cell), respectively. Cell pellets from 1.4 x 109 of "light" 
and "heavy" cells were combined in 1:1 ratio. Affinity purification of the prenucleosomal 
HJURP/CENP-A/H4 complex was performed as previously described (Bailey et al., 2013) 
except that protein elution was performed with 2% SDS and heating at 95°C. 
Mass spectrometry and data analysis 
Purified CENP-A and associated proteins were precipitated using pre-chilled acetone (4 X 
volume) followed by successive washing. Dried protein pellets were reconstituted with 
0.1% RapiGest SF Surfactant (Waters) in 100 mM NH4HCO3, pH 8.0. Resuspended proteins 
were reduced using DTT, alkylated with iodoacetamide, and digested using trypsin. Since 
trypsin cleaves only after lysines and arginines, this ensures that every resulting peptide 
will contain at least one lysine or arginine, so that all heavy peptides are distinguishable 
from their corresponding light peptides by predictable mass differences. Rapidgest was 
removed by adding 0.5% TFA and incubation for 30min at 37°C. The peptides were 
desalted with StageTips (Rappsilber et al., 2007), followed by phosphopeptide enrichment 
by TiO2 prior to analysis by Q-Exactive Hybrid Quadrupole-Orbitrap mass spectrometer 
(Thermo Fisher Scientific). The pFind search engine was used to search the UniProt human 
protein database to identify peptides (Wang et al., 2007). Quantification was done using 
extracted-ion chromatograms (XICs) of each light and heavy peptide pair, and L/H ratio 
represents the ratio of total area under each elution peak. Mass spectra of a representative 
non-phosphorylated HJURP peptide from the flow through in Figure 3 of samples from cells 
containing HJURP and HJURPAxA had a retention time range of 28.75-29.89min, which 
includes all scans in both runs in which the peptide was detectable. Mass spectra of the 
phosphopeptide containing pS210/pS11, from the elution of the phospho-enrichment from 
cells containing HJURP and HJURPAxA had a retention time range of 24.00-25.48min, which 
includes all scans from both runs in which the peptide was detectable. 
Phospho-specific anybody generation, application and phosphatase treatment 
 
Phospho-specific rabbit antibody for M18BP1 was produced by immunization of 2 rabbits 
with phosphorylated peptide ( (NH2-)CKAYILV (pT)PLKSRK (-CONH2)), and subsequent 
affinity purification of both sera (Innovagen AB, SE-22370 Lund, Sweden). 106 of 
transiently transfected HEK293T carrying either GFP M18BP1 or GFP M18BP1T653A were 
lysed in buffer containing 75mM HEPES pH 7,5, 150mM NaCl, 2mM MgCl2, 0,1% NP-40, 5% 
Glycerol, 2mM EDTA supplemented with Roche complete protease and phosphatase 
inhibitors. Lysates were spun at 4°C for 5 min at 15,000 x g. Supernatants were either left 
untreated or 300 units of Lambda phosphatase was added. All samples were incubated for 
30 min at 30°C. Reaction was stopped by addition of 4 x Orange sample buffer. For assaying 
Cdk dependent phosphorylation of M18BP1, transiently transfected Hek293T were treated 
with 100µM of Roscovitine for 30min, or treated for DMSO. Protein extracts were 
separated by SDS-PAGE and probed with pT653 and GFP (Chromotek) antibodies. 
Fluorescence activated cell sorting (FACS) for cell cycle profile was performed based on 
propidium iodide staining as described (Silva et al., 2012). 
Immunofluorescence and pre-extraction procedure 
Procedures are essentially as described (Bodor et al., 2012). Briefly, all cell lines were 
grown on glass coverslips coated with poly-L lysine (Sigma-Aldrich) and fixed with 4% 
formaldehyde (Thermo Scientific) for 10 min followed by permeabilization in 0.1% Triton 
X-100. HeLa cells were stained with anti-cyclin B1 (1:50; sc-245, Santa Cruz) and anti-
CENP-T (Barnhart et al., 2011). Secondary antibodies used were either FITC-conjugated 
anti-mouse (Jackson Immunoresearch Laboratories) or Dy680 conjugated anti-rabbit 
antibody (Rockland Immunochemicals). Cells were stained with DAPI (40, 6-diamidino-2-
phenylindole; Sigma-Aldrich) before mounting in Mowiol. For detecting GFP HJURPAxA on 
G2 centromeres, HeLa CENP-A SNAP cells transiently expressing the construct were pre-
extracted for 5min using CSK buffer (10mM Pipes-KOH pH7, 100mM NaCL, 300mM Sucrose 
and 3mM MgCl2) supplemented with 0.3% of Titon X-100. Subsequently, cells were washed 
one time with CSK buffer, followed by PBS wash and fixation for 22 min with 4% 
formaldehyde. Cells were counterstained using anti-CENP-T (Barnhart et al., 2011) and 
anti-Aurora B (1:100; BD transduction laboratories). GFP HJURPAxA signal was amplified 
using GFP-Booster Atto488 (Chromotek). 
DAPI area as a measure of cell cycle position 
To identify G2 cells in experiment presented in Figure 6 we synchronised cells in early S 
phase (by double Thymidine block), G2 phase (by double Thymidine block and 7h of 
release), late G2 (by an overnight treatment with RO3306 (Roche)) or left them 
asynchronous. Using these synchronized populations we established a cut-off for DAPI area 
size of G2 cells for each experiment. Following image acquisition, thresholding parameters 
selecting isolated DAPI areas were manually adjusted using ImageJ software. Subsequently, 
these parameters were propagated to all data sets, and an average DAPI area of each cell 
cycle stage was determined. Cells were identified as G2 if DAPI area was at least two 
standard deviations above the average DAPI area size of the S phase population. We 
confirmed that these values completely overlapped to the averages of DAPI area size 
coming from G2 synchronized populations (double thymidine released or RO3306 treated). 
All cells that had an equal or smaller DAPI area size from average values of S phase 
population were excluded from the analysis. 
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